WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERT Prostate Cancer Stem Cells.

Cancer Res

State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Published: May 2017

AI Article Synopsis

  • Cancer stem-like cells (CSCs) contribute significantly to cancer growth and the likelihood of cancer returning after treatment, but how external factors influence their behavior remains unclear.
  • WNT3a promotes the self-renewal and symmetric division of hTERT prostate cancer cells, reducing their asymmetric division and activating the WNT/β-catenin signaling pathway.
  • The study reveals that the CSC characteristics of hTERT prostate cancer cells rely, in part, on β-catenin, highlighting the impact of the tumor environment on CSC behavior.

Article Abstract

Cancer stem-like cells (CSC) drive cancer progression and recurrence. Self-renewal expansion of CSC is achieved through symmetric cell division, yet how external stimuli affect intracellular regulatory programs of CSC division modes and stemness remains obscure. Here, we report that the hTERT prostate cancer cells exhibit CSC properties, including a stem cell-associated gene expression signature, long-term tumor-propagating capacity and epithelial-to-mesenchymal transition. In promoting the self-renewal symmetric division of hTERT prostate cancer cells, WNT3a dramatically decreased the ratio of hTERT prostate cancer cells undergoing asymmetric division. Increased WNT/β-catenin signal activation was also detected in hTERT prostate cancer cells. hTERT-mediated CSC properties were at least partially dependent on β-catenin. These findings provide novel cellular and molecular mechanisms for the self-renewal of CSC orchestrated by tumor microenvironmental stimuli and intracellular signals. .

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1887DOI Listing

Publication Analysis

Top Keywords

htert prostate
20
prostate cancer
20
cancer cells
16
self-renewal symmetric
8
symmetric cell
8
cell division
8
division htert
8
csc properties
8
cancer
7
cells
6

Similar Publications

Breast cancer cells utilize T3 to trigger proliferation through cellular Ca modulation.

Cell Commun Signal

November 2024

Division of Molecular Biology and Biochemistry, Medical University of Graz, Neue Stiftingtalstraße 6/IV, Graz, 8010, Austria.

High levels of thyroid hormones are linked to increased risk and advanced stages of breast cancer. Our previous work demonstrated that the biologically active triiodothyronine (T3) facilitates mitochondrial ATP production by upregulating Ca handling proteins, thereby boosting mitochondrial Ca uptake and Krebs cycle activity. In this study, different cell types were utilized to investigate whether T3 activates a Ca-induced signaling pathway to boost cancer cell proliferation.

View Article and Find Full Text PDF

Prostate cancer (PCa) is the most common cancer diagnosed in men worldwide and was the second leading cause of cancer-related deaths in US males in 2022. Prostate cancer also represents the second highest cancer mortality disparity between non-Hispanic blacks and whites. However, there is a relatively small number of prostate normal and cancer cell lines compared to other cancers.

View Article and Find Full Text PDF

The antiproliferative properties of metformin and silodosin have been observed in prostate cancer. Furthermore, it is hypothesized that the molecular pathways related to these drugs may impact the levels of human telomerase reverse transcriptase (hTERT) in prostate cancer cells. The aim of this study was to assess the effect of metformin and silodosin on the levels of hTERT in metastatic castration-resistant prostate cancer (mCRPC) cells.

View Article and Find Full Text PDF

A promising de novo approach for the treatment of Castration-resistant prostate cancer (CRPC) exploits cell-mediated enzyme prodrug therapy comprising cytosine deaminase (CD) and fluorouracil (5-FC). The aim of this study was to determine the potential of bacterial CD-overexpressing hTERT-immortalized human adipose stem cells (hTERT-ADSC.CD) to suppress CRPC.

View Article and Find Full Text PDF

Prostate cancer (PCa) is the most common cancer diagnosed in men worldwide and the second leading cause of cancer-related deaths in US males in 2022. Prostate cancer also represents the second highest cancer mortality disparity between non-Hispanic blacks and whites. However, there is a relatively small number of prostate normal and cancer cell lines compared to other cancers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!